Multiple Assemblies exist for SMTL entry 2i47
Crystal structure of catalytic domain of TACE with inhibitor; X-RAY DIFFRACTION 1.90 Å

	SMTL ID 2i47.1 Ligands ZINC ION; N-{(2R)-2-[2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoyl}-3-methyl-L-valyl-N-(2-aminoethyl)-L-alaninamide Polypeptides ADAM 17 Oligo-state monomer
	SMTL ID 2i47.2 Ligands ZINC ION; N-{(2R)-2-[2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoyl}-3-methyl-L-valyl-N-(2-aminoethyl)-L-alaninamide Polypeptides ADAM 17 Oligo-state monomer
	SMTL ID 2i47.3 Ligands ZINC ION; 4-({[4-(BUT-2-YN-1-YLOXY)PHENYL]SULFONYL}METHYL)-1-[(3,5-DIMETHYLISOXAZOL-4-YL)SULFONYL]-N-HYDROXYPIPERIDINE-4-CARBOXAMIDE Polypeptides ADAM 17 Oligo-state monomer
	SMTL ID 2i47.4 Ligands ZINC ION; 4-({[4-(BUT-2-YN-1-YLOXY)PHENYL]SULFONYL}METHYL)-1-[(3,5-DIMETHYLISOXAZOL-4-YL)SULFONYL]-N-HYDROXYPIPERIDINE-4-CARBOXAMIDE Polypeptides ADAM 17 Oligo-state monomer